Search Within

Andrew D Seidman

  1. "Surgery"
Formats
  1. Journal Article (8)
  2. Meeting Abstract (8)
Groups
  1. Breast Medicine Service (16)
  2. Department of Medicine (16)
  3. Solid Tumor Oncology Division (16)
  4. Surgery (16)
  5. Survivorship Research (14)
  6. Epidemiology and Biostatistics (12)

More Groups

People
  1. Clifford Hudis (7)
  2. Shanu Modi (7)
  3. Larry Norton (6)
  4. Mark Robson (6)
  5. Sujata Patil (6)
  6. Chau Dang (5)

More People

Years
  1. 2024 (1)
  2. 2023 (2)
  3. 2022 (1)
  4. 2017 (1)
  5. 2015 (1)
  6. 2012 (2)

More Years

Publications
  1. Journal of Clinical Oncology (6)
  2. Cancer Research (3)
  3. Cancer (2)
  4. npj Breast Cancer (2)
  5. Annals of Oncology (1)
  6. Breast Cancer Research and Treatment (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (6)
  2. American Association for Cancer Research (4)
  3. Nature Publishing Group (2)
  4. Wiley Blackwell (2)
  5. Oxford University Press (1)
  6. Springer (1)

Results (16)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Invasive disease-free survival and brain metastasis rates in patients treated with neoadjuvant chemotherapy with trastuzumab and pertuzumab
    Journal Article

    Chew, S. M.; Ferraro, E.; Chen, Y.; Barrio, A. V.; Kelly, D.; Modi, S.; Seidman, A. D.; Wen, H.; Brogi, E.; Robson, M.; more...
    npj Breast Cancer (2024)

    Fulltext@MSK | Save
  • Prognostic implications of HER2 gain in patients with HR+/ HER2-breast cancer (BC) and TNBC after neoadjuvant chemotherapy (NAC)
    Meeting Abstract

    Ferraro, E.; Chew Minmin, S.; Nemirovsky, D.; Chen, Y.; Barrio, A. V.; Modi, S.; Seidman, A.; Wen, H.; Brogi, E.; Robson, M.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Invasive disease free survival and brain metastasis rates in patients treated with neoadjuvant chemotherapy with trastuzumab and pertuzumab
    Meeting Abstract

    Chew, S.; Ferraro, E.; Chen, Y.; Barrio, A. V.; Kelly, D. W.; Modi, S.; Seidman, A. D.; Wen, H. Y.; Brogi, E.; Robson, M. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Incidence of brain metastases in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy with trastuzumab and pertuzumab
    Journal Article

    Ferraro, E.; Singh, J.; Patil, S.; Razavi, P.; Modi, S.; Chandarlapaty, S.; Barrio, A. V.; Malani, R.; Mellinghoff, I. K.; Boire, A.; more...
    npj Breast Cancer (2022)

    Fulltext@MSK | Save
  • Oncologic outcome of pregnancy associated breast cancer: A case-control study
    Meeting Abstract

    McCartan, D.; Kamer, S.; Eaton, A.; Seidman, A.; Murphy, C.; Gemignani, M.; Goldfarb, S.
    Cancer Research (2017)

    Fulltext@MSK | Save
  • Integration of multi-modality treatment planning for early stage breast cancer (BC) into Watson for Oncology, a Decision Support System: Seeing the forest and the trees
    Meeting Abstract

    Seidman, A. D.; Pilewskie, M. L.; Robson, M. E.; Kelvin, J. F.; Zauderer, M. G.; Epstein, A. S.; Kris, M. G.; Fu, J.; Keesing, J.; Caroline, A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Tolerability and efficacy of targeting both mTOR and HER2 signaling in trastuzumab-refractory HER2+ metastatic breast cancer
    Meeting Abstract

    Gajria, D.; King, T.; Pannu, H.; Sakr, R.; Modi, S.; Drullinsky, P.; Syldor, A.; Patil, S.; Seidman, A.; Norton, L.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Current or recent pregnancy is associated with adverse pathologic features but not impaired survival in early breast cancer
    Journal Article

    Murphy, C. G.; Mallam, D.; Stein, S.; Patil, S.; Howard, J.; Sklarin, N.; Hudis, C. A.; Gemignani, M. L.; Seidman, A. D.
    Cancer (2012)

    Fulltext@MSK | Save
  • Combined inhibition of mTORC1 with temsirolimus and HER2 with neratinib: A phase I study in patients with metastatic HER2-amplified breast cancer
    Meeting Abstract

    Gajria, D.; King, T. A.; Pannu, H.; Sakr, R.; Seidman, A. D.; Syldor, A.; Patil, S.; Maybody, M.; Norton, L.; Rosen, N.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Combined inhibition of mTORC1 with temsirolimus and HER2 with neratinib: A phase I/II study in patients with metastatic HER2-amplified or triple-negative breast cancer
    Meeting Abstract

    Gajria, D.; King, T.; Pannu, H.; Sakr, R.; Seidman, A. D.; Modi, S.; Dickler, M.; Drullinsky, P.; Syldor, A.; Sujata, P.; more...
    Cancer Research (2011)

    Fulltext@MSK | Save